Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation

Part of paid clinical trials in Springfield, Massachusetts.

Sponsor
Baystate Medical Center
Study ID
NCT06527820
Status
Recruiting
Apply to this trial

Conditions

  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Talk About It (conversation aid) — BEHAVIORAL
    "Talk About It" is a conversation aid aimed to increase awareness of options and prompt discussion.

Study Details

The increasing morbidity and mortality of the opioid epidemic has necessitated a reevaluation of current addiction treatment paradigms: medications for opioid use disorder, such as buprenorphine and methadone, are effective in decreasing one's risk of death and disability from opioid use, but are underutilized and often difficult to access. The 5000 Emergency Departments (EDs) in the US are potential additional locales for medication initiation, but currently only a small minority of ED patients with opioid use disorder are started on medications. This study will refine and pilot an intervention called Talk About It which aims to foster patient-centered care, 'meet patients where they are' for addiction treatment, and increase treatment initiation and adherence via facilitating Shared Decision-Making in the ED around these potentially life-saving options.

Key Dates

Start date
Jun 1, 2024
Status verified
Jul 2024
Primary completion
May 31, 2026
Completion
Aug 30, 2026

Study Design

Enrollment
75 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

Uptake of Talk About It (1) [ Time Frame: At 18 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Baystate Medical CenterSpringfieldMassachusetts01199
Jillian Tozloski
[email protected]

Find similar trials in Springfield, MA

By research site
Baystate Medical Center· Springfield, MA

Related Studies